| |
| |
|
| Insider
Information: |
Scheer David |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
188,389 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,389 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achillion Pharmaceuticals Inc |
ACHN |
|
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
|
Tengion Inc |
TNGN |
Director |
|
0 |
2010-04-14 |
188,389 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2016-11-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$398,469 |
I/I |
(63,249) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2020-01-28 |
4 |
D |
$6.30 |
$185,945 |
D/D |
(29,515) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2019-11-13 |
4 |
S |
$6.31 |
$66,197 |
D/D |
(10,485) |
29,515 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
|
– • – |
2019-11-13 |
4 |
OE |
$3.28 |
$65,600 |
D/D |
20,000 |
40,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2018-12-14 |
4 |
OE |
$1.05 |
$21,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2016-11-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(521,350) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2016-11-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2015-12-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(65,869) |
521,350 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2013-08-21 |
4 |
S |
$84.57 |
$1,691,638 |
I/I |
(20,000) |
620,154 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2011-03-11 |
4 |
B |
$15.36 |
$92,252 |
D/D |
6,006 |
650,154 |
2.39 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2011-03-10 |
4 |
B |
$15.11 |
$60,349 |
D/D |
3,994 |
644,148 |
2.39 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2010-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
640,154 |
|
- |
|
| TNGN |
Tengion Inc |
Director |
– • – |
2010-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
12,894 |
188,389 |
0 |
- |
|
| TNGN |
Tengion Inc |
Director |
– • – |
2010-04-14 |
4 |
B |
$5.00 |
$100,000 |
I/I |
20,000 |
175,495 |
2.1 |
- |
|
| TNGN |
Tengion Inc |
Director |
– • – |
2010-04-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
155,495 |
|
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2006-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,939 |
63,249 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Director |
– • – |
2006-10-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
60,310 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
